Anavex Life Sciences (AVXL) Earnings Date & Reports

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AVXL is expected to report earnings to rise 7.14% to -15 cents per share on May 08

Anavex Life Sciences AVXL Stock Earnings Reports

Q1'25

Est.

$-0.15

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.02

Q1'24

Missed

by $0.02

The last earnings report on February 12 showed earnings per share of -14 cents, beating the estimate of -16 cents. With 320.70K shares outstanding, the current market capitalization sits at 728.15M.

View a ticker or compare two or three

Compare

AVXL